This is a placebo controlled randomized controlled trial of perioperative use of tamsulosin to prevent postoperative urinary retention in female pelvic reconstructive surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
132
Tamsulosin or placebo will be given for 3 days prior to surgery and one week after surgery to determine its effects on postoperative urinary retention.
Tamsulosin or placebo will be given for 3 days prior to surgery and one week after surgery to determine its effects on postoperative urinary retention.
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
University Hospitals
Cleveland, Ohio, United States
Postoperative Urinary Retention
Failed voiding trial upon removal of catheter
Time frame: Within 72 hours of surgery
International Prostate Symptom Score
Total and subscale scores reported. Total score range 0-35, with 0 being less symptomatic and 35 being more symptomatic. Total score is sum of individual questions. Seven subgroups address incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining, nocturia. Each subgroup is scored 0-5 with 5 being most symptomatic. The last question is independent, rates quality of life from 0 (best) to 6 (worst)
Time frame: Within 1 week of surgery
Postoperative Urinary Tract Infection
Treated for urinary tract infection with antibiotics or urinalysis or urine culture suggests infection.
Time frame: Within 6 weeks after surgery
Sent Home With Catheterization
Urinary retention that required homegoing catheterization
Time frame: within 6 weeks of surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.